Evexia is your one-stop solution for COVID-19 testing options. Evexia Diagnostics has been a trusted service provider to clinicians in the healthcare industry for over 13 years and is uniquely positioned to offer validated, rapid, and reliable testing options to help address the impact of the COVID-19 crisis. Presently, we are partnering with local and national companies, municipalities, and state governments that have an interest in utilizing COVID-19 testing to assess the current burden on their organization and workforce.
As this pandemic progresses, it will be vital to understand the testing options available and how they are best applied in different scenarios. For example, it will be instrumental knowing whether someone has already had COVID-19 and may now possess immunity to the virus, not only in helping employees transition back to work but also providing your organization with the ability to make informed and strategic decisions regarding the readiness of preparations for resuming operations.
Evexia currently offers 3 distinct COVID-19 tests using different specimen types and different testing technologies that lend particular insights and can each contribute to a more complete picture of the SARS-CoV-2 viral progression. Evexia has created a testing guidance resource, based on specific conditions and criteria, to help provide additional support on which test would be most appropriate for your employees and team members. There is an interactive version available on our COVID-19 Repository Page, however, a PDF copy of this insightful tool can also be accessed here. All testing is performed by independent, CLIA-certified high-complexity laboratories, and below is a brief breakdown of the choices at your disposal.
The COVID-19 Antibody Test offered by Evexia Diagnostics is a validated serological assay that detects SARS-CoV-2 IgM & IgG antibodies and offers the expanded ability to determine a current infection (IgM), as well as a past infection and concomitant immunity (IgG). This unique, high-performance serology test has a 100% sensitivity and 100% specificity. The COVID-19 Antibody Test requires a simple blood draw and results are available within 24 hours. This test is ideally suited for asymptomatic individuals who may have already been infected with SARS-CoV-2 and could now possess immunity.
In addition to the COVID-19 Antibody Test, Evexia Diagnostics offers a couple of COVID-19 Respiratory PCR Test options that detect the virus in symptomatic individuals and produce rapid results within 24-hours. These test options can be performed utilizing specimens from either a nasopharyngeal or nasal swab. Be aware this test can only identify an active SARS-CoV-2 viral infection and does not determine prior infection or immunity status.
Evexia also offers a COVID-19 PCR Stool Test for monitoring viral shedding in the GI tract following the symptomatic recovery of the infection. Based on the latest research, viral shedding can continue to occur, post-recovery, in the stool for up to 30-45 days. Therefore, being able to track viral shedding will likely become a crucial component to prevent further transmission of the virus after an individual no longer displays symptoms.
Please contact us today at 888-852-2723. We are eager to assist you in identifying and implementing the best solutions available to support your business and facilitating a full return to your operations.